广告Discover A New TROP2-Directed ADC For HR+ HER2- Unresectable Or Metastatic Breast Cancer. Healthcare Professionals: See The Mechanism Of Action For A New Therapy For HR+ HER2- mBC.
Types: Efficacy & Safety, Mechanism Of Action, Dosing & Administration
English
保存
分享
更多